AC-1

Trials studying AC-1

• phase2A Study of AC-101 Tablets in Patients With Ulcerative Colitisnot yet recruitingn=153
• phase2A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitisrecruitingn=24
• phase3A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Oldercompletedn=2,852
• phase1Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients with Granuloma Annularecompletedn=13
• phase2Phase 2 Study of TAC-101 Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone in Japanese Patients With Advanced Hepatocellular Carcinomaterminatedn=54
• phase2Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapyterminatedn=52
• phase2A Study of TAC-101 in Combination With TACE Versus TACE Alone in Asian Patients With Advanced Hepatocellular Carcinomawithdrawn
• phase3A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adultscompletedn=2,600